Medopharm — Azithromycin Exporter Profile
Indian Pharmaceutical Exporter · #15 for Azithromycin · $2.3M export value · DGFT Verified
Medopharm is the #15 Indian exporter of Azithromycin with $2.3M in export value and 103 verified shipments. Medopharm holds a 1.2% market share in Azithromycin exports across 23 countries. The company exports 21 pharmaceutical products worth $50.2M across 10 therapeutic categories.
Medopharm — Azithromycin Export Profile: Buyers & Destinations
Where Does Medopharm Export Azithromycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| NETHERLANDS | $809.1K | 30 | 29.8% |
| UNITED ARAB EMIRATES | $625.3K | 33 | 23.0% |
| DENMARK | $224.3K | 5 | 8.3% |
| ETHIOPIA | $173.7K | 8 | 6.4% |
| HONDURAS | $136.5K | 7 | 5.0% |
| SINGAPORE | $109.8K | 5 | 4.0% |
| YEMEN | $100.0K | 2 | 3.7% |
| SUDAN | $99.0K | 2 | 3.6% |
| THAILAND | $71.8K | 7 | 2.6% |
| NIGERIA | $59.9K | 4 | 2.2% |
Medopharm exports Azithromycin to 25 countries. The largest destination is NETHERLANDS accounting for 29.8% of Medopharm's Azithromycin shipments, followed by UNITED ARAB EMIRATES (23.0%) and DENMARK (8.3%). These destinations reflect Medopharm's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Azithromycin from Medopharm?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| IMRES | NETHERLANDS | $250.2K | 7 |
| M/S. IMRES | NETHERLANDS | $180.2K | 4 |
| IDA TRADING MEAC/OKUEHNE+NAGEL LLC. | UNITED ARAB EMIRATES | $170.8K | 8 |
| THE MEDICAL EXPORT GROUP | NETHERLANDS | $135.7K | 7 |
| M/S. CHF INTERNATIONAL | HONDURAS | $100.0K | 2 |
| UNICEF SANAA | YEMEN | $100.0K | 2 |
| IDA TRADING MEA C/OKUEHNE+NAGEL LLC | UNITED ARAB EMIRATES | $86.5K | 7 |
| IDA TRADING MEAC OKUEHNE NAGEL LLC | UNITED ARAB EMIRATES | $86.2K | 6 |
| IMPERIAL MEDICAL SOLUTIONS FZE | UNITED ARAB EMIRATES | $81.1K | 3 |
| M/S. UNICEF SUPPLY DIVISION | DENMARK | $80.1K | 2 |
Medopharm supplies Azithromycin to 60 buyers globally. The largest buyer is IMRES (NETHERLANDS), followed by M/S. IMRES (NETHERLANDS) and IDA TRADING MEAC/OKUEHNE+NAGEL LLC. (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Azithromycin Export Value and How Much Does Medopharm Contribute?
India exported $74.0M worth of Azithromycin through 15,000 shipments from 853 suppliers to 169 countries, serving 2,397 buyers globally. Medopharm contributes $2.3M to this total, accounting for 1.2% of India's Azithromycin exports. Medopharm ships Azithromycin to 25 countries through 60 buyers.
What Is the Average Shipment Value for Medopharm's Azithromycin Exports?
Medopharm's average Azithromycin shipment value is $22.2K per consignment, based on 103 shipments totaling $2.3M. The largest destination is NETHERLANDS (29.8% of Medopharm's Azithromycin exports).
How Does Medopharm Compare to Other Indian Azithromycin Exporters?
Medopharm ranks #15 among 853 Indian Azithromycin exporters with a 1.2% market share. The top 3 exporters are LUPIN LIMITED ($11.0M), ALEMBIC PHARMACEUTICALS LIMITED ($8.7M), CIPLA LIMITED ($8.4M). Medopharm processed 103 shipments to 23 destination countries.
What Azithromycin Formulations Does Medopharm Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| AZITHROMYCIN TABLETS USP 250MG | $178.9K | 10 |
| AZITHROMYCIN TABLETS USP 250MG (153000 X | $150.0K | 3 |
| AZITHROMYCIN TABLETS USP 500MG (418000 X | $100.0K | 2 |
| AZITHROMYCIN TABLETS USP 250 MG (177320X 1 X 6 ) -BOX | $100.0K | 2 |
| AZITHROMYCIN TABLETS USP 250MG (107501 X | $99.0K | 2 |
| AZITHROMYCIN TABLETS USP 500MG 67000 X | $90.3K | 3 |
| AZITHROMYCIN TABLETS USP 500MG (33340 X | $81.0K | 6 |
| AZITHROMYCIN TABLETS USP 250MG ( 91000 X1 X 6) BOX | $75.8K | 2 |
| AZITHROMYCIN TABLETS USP 250MG 76500 X1 X 4 - BOX | $61.7K | 2 |
| AZITHROMYCIN TABLETS USP 250MG 33340 X | $61.6K | 5 |
Medopharm exports 79 distinct Azithromycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is AZITHROMYCIN TABLETS USP 250MG with 10 shipments worth $178.9K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
How Does Medopharm Compare to Nearest Azithromycin Exporters?
Exporters ranked immediately above and below #15 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 11 | EUGIA PHARMA SPECIALITIES LIMITED | $2.8M | 56 | 2 | $50.0K |
| 14 | SCOTT EDIL PHARMACIA LIMITED | $2.7M | 68 | 18 | $40.3K |
| 15 | MEDOPHARM ★ | $2.3M | 103 | 23 | $22.2K |
| 12 | GLAND PHARMA LIMITED | $1.1M | 21 | 3 | $50.0K |
| 9 | ANANT PHARMACEUTICS | $550.0K | 11 | 1 | $50.0K |
Medopharm ranks #15 among 853 Indian Azithromycin exporters. Average shipment value of $22.2K compared to the market average of $86.8K. The closest competitors by value are EUGIA PHARMA SPECIALITIES LIMITED and SCOTT EDIL PHARMACIA LIMITED.
Which Indian Ports Ship Azithromycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 2,394 | 16.0% |
| SAHAR AIR | 2,211 | 14.7% |
| DELHI AIR CARGO ACC (INDEL4) | 1,693 | 11.3% |
| DELHI AIR | 1,106 | 7.4% |
| JNPT/ NHAVA SHEVA SEA | 902 | 6.0% |
| NHAVA SHEVA SEA (INNSA1) | 870 | 5.8% |
| Bombay Air | 618 | 4.1% |
| JNPT | 408 | 2.7% |
What Other Antibiotics Products Does Medopharm Export?
Medopharm also exports these antibiotics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Medopharm's Azithromycin Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Medopharm. The Israel-Iran conflict has disrupted Red Sea shipping routes, leading to increased freight costs and extended transit times. These disruptions have particularly impacted trade corridors through the Persian Gulf and the Strait of Hormuz, vital for India's drug shipments. (pharmaceuticalcommerce.com)
Conversely, US-China trade tensions have prompted the United States to seek alternative sources for pharmaceuticals, potentially benefiting Indian exporters. However, the imposition of 100% tariffs on branded or patented pharmaceutical products by the US in October 2025 poses a significant challenge. While generic drugs may remain largely unaffected, companies like Medopharm must navigate these policy shifts carefully. (itisbl.com)
The recent India–European Union Free Trade Agreement, concluded in January 2026, offers a favorable development. The agreement eliminates tariffs on most European pharmaceutical exports to India and vice versa, potentially enhancing market access for Indian companies in the EU. (en.wikipedia.org)
Medopharm — Regulatory Compliance & Quality Standards
India's pharmaceutical industry has made significant strides in regulatory compliance, with the country surpassing the US in the number of FDA-registered generic manufacturing sites as of 2024. This achievement reflects improved adherence to international quality standards, a critical factor for exporters like Medopharm. (business-standard.com)
However, the industry faces challenges related to quality compliance, as evidenced by incidents involving contaminated products. Maintaining rigorous quality control measures is essential for sustaining global trust and market access. (economictimes.indiatimes.com)
About Medopharm
Medopharm exports 21 products worth $50.2M. Beyond Azithromycin, top products include Amoxicillin, Metronidazole, Paracetamol, Albendazole, Ciprofloxacin. View the complete Medopharm profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Azithromycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Azithromycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Medopharm matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 131 individual customs records matching Medopharm exporting Azithromycin, covering 79 formulations to 25 countries via 60 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 169+ countries, 2,397+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Azithromycin Export Data from Medopharm
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Medopharm's Azithromycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Medopharm
Full Company Profile →
21 products · $50.2M total trade · 10 categories
Azithromycin Stats
Company Overview
Top Products by Medopharm
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Medopharm.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Azithromycin. For current shipment-level data, contact TransData Nexus.